Список литературы

1. Баркаган З.С., Момот А.П. Диагностика и контролируемая терапия нарушений гемостаза. - М.: Ньюдиамид, 2001.

2. Момот А.П. Принципы и алгоритмы клинико-лабораторной диагностики. - СПб: ФормаТ, 2006.

3. Основы клинической гемостазиологии и гемореологии: монография / Под ред. И.Л. Давыдкина, А.П. Момота, Н.И. Зозули, Е.В. Ройтмана. - Самара: ООО ИПК "Самарская Губерния", 2017.

4. Руководство по гематологии в 3 томах / Под ред. А.И. Воробьева. - М.: Ньюдиамед, 2005.

5. Шабалов Н.П. Гемостаз в динамике первой недели жизни как отражение механизмов адаптации к внеутробной жизни новорожденных. Педиатрия 2000; 3: 84 - 91.

6. Abshire TC. Prophylaxis and von Willebrand's disease (VWD). Thromb. Res. 2006; 118 (Suppl. 1): S3 - S7.

7. Brown DL. Congenital bleeding disorders. Curr Probl Pediatr Health Care 2005; 35: 38 - 62.

8. Budde U, Pieconka A, Will K, Schneppenheim R. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification. Semin. Thromb. Hemost. 2006; 32: 515 - 521.

9. Caleizi C, Tsakiris DA, Behringer H, et al Two consecutive pregnancies and deliveries in patients with von Willebrand disease type 3. Haemophilia 1998; 4(6): 845 - 849.

10. Diagnosis and Management of Von Willebrand Disease in The Netherlands De Wee E.M., Frank W.G. Leebeek F.W.G, Eikenboom J.C.J., Diagnosis and Management of Von Willebrand Disease in The Netherlands. Semin.Thromb.Hemost. 2011; 37(5): 480 - 48.

11. Desch KC, Ozel AB, Siemieniak D, et al. Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association. Proc Natl Acad Sci USA. 2013; 110(2): 588 - 593.

12. Drewke E, Krey S, Schneppenheim R, Budde U. A variant of von Willebrand disease (Type 2N) resembling phenotypically mild or moderately severe haemophilia. Infusionsther Transfusionsmed 1995; 22 (Suppl. 1): 48 - 50.

13. Favaloro EJ, Bonar RA, Meiring M, et al. Evaluating errors in the laboratory identification of von Willebrand disease in the real world. Thromb Res. 2014; 134(2): 393 - 403.

14. Federici AB, Bucciarelli P, Castaman G, et al. The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease: a prospective cohort study of 796 cases. Blood. 2014: blood-2014-02-557264.

15. Gandhi R, Evans HM, Mahomed SR, Mahomed NN. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes. 2013; 07(6): 184.

16. Laffan MA, Lester W, O'Donnell JS, et al. The diagnosis and management of von Willebrand disease: A United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br. J. Haematol. 2014; 167(4): 453 - 465.

17. Lillicrap D. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Blood. 2013; 122(23): 3735 - 3740.

18. Loon J. et al. Genome-wide association studies identify genetic loci for low von Willebrand factor levels. European Journal of Human Genetics (2016) 24, 1035 - 1040.

19. Mazurier C, Meyer D. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease - results of an international survey. Thromb. Haemost. 1996; 76: 270 - 274.

20. Mannucci PM. Treatment of von Willebrand's disease. N. Engl. J. Med. 2004; 351: 683 - 694.

21. Mannucci PM, Chediak J, Hanna W, Byrnes J, Ledford M, Ewenstein BM, Retzios AD, Kapelan BA, Schwartz RS, Kessler C; Alphanate Study Group. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: A prospective, multicenter study. Blood. 99. 450 - 6.

22. Martinovitz U, Schulman S, Horoszowski H, Heim M. Role of fibrin sealants in surgical procedures on patients with hemostatic disorders. Clin. Orthoped 1996; 328: 65 - 75.

23. Lassila R et al. Nordic guidelines for diagnosis and management of von Willebrand disease. Semin Thromb Hemost 2011; 37: 495 - 502.

24. Paul LF, Giangrande PLF. Pregnancy in women with inherited bleeding disorders. World Federation of Haemophilia. Treatment of Hemophilia 2003; 29: 9.

25. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. J Thromb Haemost. 2010 Sep; 8(9): 2063 - 5.

26. Thompson AR, Gill JC, Ewenstein BM, Mueller-Velten G, Schwartz BA. Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P). Haemophilia 2004 Jan; 10(1): 42 - 51.

27. Quiroga T, Goycoolea M, Belmont S, et al. Quantitative impact of using different criteria for the laboratory diagnosis of type 1 VWD. J Thromb Haemost. 2014; 12(8): n/a - n/a.

28. Quiroga, T., Goycoolea, M., Panes, O., Aranda, E., Martinez, C., Belmont, S., Munoz, B., Zuniga, P., Pereira, J. & Mezzano, D. (2007) High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica, 92, 357 - 365.

29. Rodeghiero F, Castaman G, Dini I. Epidemiological investigations of the prevalence of von Willebrand's disease. Blood 1987; 69: 454 - 459.

30. Sadler JE, Budde U, Eikenboom JC, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the subcommittee on von Willebrand factor. J Thromb. Haemost. 2006; 4 (10): 2103 - 2114.

31. Schneppenheim R, Budde U, Krey S, et al. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1. Thromb. Haemost. 1996; 76: 598 - 602

32. Scharrer I. Women with von Willebrand disease. Haemostasiologie 2004; 24: 44 - 49.

33. Tosetto A, Castaman G, Plug I, Rodeghiero F, Eikenboom J. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. J Thromb Haemost. 2011; 9(6): 1143 - 1148.

34. Van Schie MC, Wieberdink RG, Koudstaal PJ, et al. Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam Study. J Thromb Haemost. 2012; 10(4): 550 - 556.